Abstract:Background: The goal of this study was to screen for differentially expressed exosomal miRNAs in peripheral blood samples of early-onset preeclampsia and normal pregnant patients using high-throughput sequencing methods and explore their effects on the pathogenesis of preeclampsia. Methods: Peripheral blood samples from 5 patients with early-onset preeclampsia and 5 normal pregnant women (control group) were enrolled. Then, exosomes were extracted from each sample, and the procedure was replicated three times. An Illumina HiSeq4000 sequencing platform was used to analyze exosomal miRNAs in all samples before comparison. The target genes and signaling pathway predictions and the biological function enrichments of significant and differentially expressed miRNAs were assessed using Miranda and Starbase software, as well as GO and KEGG databases. Results: Compared with the control, patients in the early-onset preeclampsia group had 65 significantly and differentially expressed exosomal miRNAs in their peripheral blood samples. The results have shown that of the 65 differentially expressed miRNAs, 17, including has-miR-6855, has-miR-7151, and has-miR-6777, were up-regulated, and 48, including has-miR-1247, has-miR-29B2, and has-miR-941, were down-regulated (p < 0.05). The Miranda and TargetScanS algorithms predicted a total of 2,231 target genes from the differentially expressed miRNAs. The Go and KEGG analyses showed that the principal biological function of these target genes was the regulation of Ras protein signal transduction, histone modification, GTPase-mediated signal transduction, and transforming growth factor (TGF)-β. Additionally, the results also showed that the major pathways involved in the regulation of these functions were the PI3K Akt, MAPK, tumor necrosis factor, and EGFR tyrosine kinase inhibition signaling pathways. Conclusions: There are significant differences in the expression profiles of exosomal miRNAs between early-onset preeclampsia patients and normal pregnant women. These differentially expressed miRNAs may not only play an important regulatory role in the occurrence of early-onset preeclampsia but also participate in its pathophysiological process through genetic regulation of a variety of biological functions and signal pathways.

Research advances of exosome in the pathogenesis of preeclampsia

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Research progress of exosomes in pathogenesis and treatment of preeclampsia

Placental exosomes in pregnancy and preeclampsia

Biogenesis and function of exosome lncRNAs and their role in female pathological pregnancy

Exosomes from Women with Preeclampsia Induced Vascular Dysfunction by Delivering Sflt (soluble Fms-Like Tyrosine Kinase)-1 and Seng (soluble Endoglin) to Endothelial Cells

Pathogenic Mechanisms of Preeclampsia with Severe Features Implied by the Plasma Exosomal Mirna Profile

Placenta-derived exosomes: potential biomarkers of preeclampsia

Overview of Extracellular Vesicles in the Pathogenesis of Preeclampsia

Research advances in biomarkers for early prediction of preeclampsia

Placenta-derived exosomes as carriers of non-coding RNAs in maternal circulation of patients with preeclampsia

Profiling of Exosomal Micrornas Expression in Umbilical Cord Blood from Normal and Preeclampsia Patients

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

Circulating Non-coding RNAs and Exosomes: Liquid Biopsies for Monitoring Preeclampsia.

Exploring the role of exosomal MicroRNAs as potential biomarkers in preeclampsia

Extracellular Vesicles and Preeclampsia: Current Knowledge and Future Research Directions

Mesenchymal stem cell-derived exosomes: a promising alternative in the therapy of preeclampsia

Small RNA sequencing reveals placenta-derived exosomal microRNAs associated with preeclampsia

Comparative Proteomic Profile of the Human Umbilical Cord Blood Exosomes between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry.

Understanding the role of soluble proteins and exosomes in non-invasive urine-based diagnosis of preeclampsia

High Throughput Sequencing Analysis of Exosomal miRNA Expressions in Early-Onset Preeclampsia Patients